Skip to content
★ Sign in to follow
SE

Susan Eylward

Executive
Insider activity · 24 months0 buys5 salesCumulative net flow
Total declarations
12
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (6 ops.)
€33k

Latest filing published 01 Sept 2026 for Imunon, Inc., €3,465.

Filing timeline

BuySale
Susan Eylward

Insider track record

Disclosed buys
0
Disclosed sells
6

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Susan Eylward: trading record in brief

This profile gathers the share dealings of Susan Eylward in Imunon, Inc. Over a trading history stretching from 25 June 2026 to 31 August 2026, the count stands at 12 filings.

On the market, this insider has only sold: 6 sales, €33k in total. The rest of the record consists of 6 share grants.

On 1 September 2026 came the latest disclosure, a share grant for €3,465 in Imunon, Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Susan Eylward

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    4,040 USD21SEC
    2,525 shares@ US$1.600.045% mcap11.3% of flowCommon StockSEC:0001437749-26-029405:0
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    3,950 USD21SEC
    2,525 shares@ US$1.56430.044% mcap11.1% of flowCommon StockSEC:0001437749-26-029405:1
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    4,041 USD21SEC
    2,449 shares@ US$1.650.044% mcap14.7% of flowCommon StockSEC:0001437749-26-028184:0
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    3,993 USD21SEC
    2,449 shares@ US$1.63030.043% mcap14.5% of flowCommon StockSEC:0001437749-26-028184:1
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    4,040 USD23SEC
    2,541 shares@ US$1.590.046% mcap20.9% of flowCommon StockSEC:0001437749-26-025661:0
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    3,977 USD23SEC
    2,541 shares@ US$1.56510.045% mcap20.5% of flowCommon StockSEC:0001437749-26-025661:1
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    3,830 USD24SEC
    2,150 shares@ US$1.78160.050% mcap34.0% of flowCommon StockSEC:0001437749-26-023948:1
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    3,935 USD24SEC
    2,150 shares@ US$1.830.051% mcap34.9% of flowCommon StockSEC:0001437749-26-023948:0
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    1,757 USD24SEC
    920 shares@ US$1.910.021% mcap50.4% of flowCommon StockSEC:0001437749-26-022944:0
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    1,730 USD24SEC
    920 shares@ US$1.880.021% mcap49.6% of flowCommon StockSEC:0001437749-26-022944:1
  • ▼
    General Counsel and Corp SecExecutivesImunon, Inc.
    0SEC
    11,800 sharesCommon StockSEC:0001437749-26-022008:1
  • ◆
    General Counsel and Corp SecExecutivesImunon, Inc.
    0SEC
    14,696 sharesCommon StockSEC:0001437749-26-022008:0

12 of 12 declarations